World AIDS Day 2018: Know the epidemic, shape the response
The tools to end new HIV infections and AIDS exist. The knowledge on how to use them is agreed upon. Nevertheless late diagnosis of HIV remains a challenges across the European Union and European Economic Area.
Every second person diagnosed with HIV has already reached an advanced stage in the infection - which is one reason for a persistent HIV epidemic in Europe This shows that reaching and testing those at risk of infection with HIV is still a public health challenge across Europe.
Increasing testing coverage and uptake, especially for those most at risk, is an essential element of any strategy to eliminate HIV in the European Union and European Economic Area (EU/EEA). Part of this strategy: early diagnosis and linkage to care. Both bring strong individual and public health benefits as effective HIV treatment suppresses the viruses significantly which in turn means that those on treatment do not pass on the virus to others.
HIV testing provides an entry point to treatment and care and with the new ECDC guidance on integrated HIV, hepatitis B and C testing countries get the latest scientific evidence to develop, implement, improve, monitor and evaluate national or local testing guidelines and programmes for both HIV and viral hepatitis.
World AIDS Day 2018, 1 December 2018
On the occasion of the 30th anniversary of World AIDS Day, ECDC and the WHO Regional Office for Europe releases the latest data on the HIV epidemic in the European Region.
New HIV diagnoses at alarmingly high levels in the European Region despite progress in EU/EEA
28 Nov 2018 - With nearly 160 000 people newly diagnosed with HIV, 2017 marked another year of alarming numbers of new HIV diagnoses in the WHO European Region. In contrast, the European Union and European Economic Area (EU/EEA) countries reported a decline in rates of new diagnoses, mainly driven by a 20% decrease since 2015 among men who have sex with men.
HIV/AIDS surveillance in Europe 2018 - 2017 data
28 Nov 2018 - This report is the latest in a series published jointly by European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
European Testing Week, 23- 30 November 2018
Marking European Testing Week: ECDC issues integrated hepatitis and HIV testing Guidance
23 Nov 2018 - To mark European Testing Week from 23 to 30 November 2018, ECDC publishes its new Guidance on integrated viral hepatitis and HIV testing.
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
23 Nov 2018 - This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
The benefits of HIV treatment: undetectable means you do not pass on the virus
25 Jul 2018 - Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
HIV Estimates Accuracy Tool
The HIV estimates accuracy tool is a new end user application that uses statistical methods to calculate adjusted estimates from HIV surveillance data taking into account the issues of missing data and reporting delay.Read more
Ending the HIV epidemic: where does Europe stand?
30 Nov 2018 - From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia. The main issues: diagnosing those who are unaware of their HIV infection and treating them.
Quantifying unmet prevention needs among msm in europe through a multi-site bio-behavioural survey
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016
Monitoring implementation of the Dublin Declaration
Every second year, ECDC reports on the implementation of the Dublin Declaration through a series of thematic report and evidence briefsRead more
Public health guidance on prevention and control of blood-borne viruses in prison settings
23 Jul 2018 - This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.